Enhancement of humoral immunity to the hCG beta protein antigen by fusing a molecular adjuvant C3d3

Journal of Reproductive Immunology
Xiu-Li WangXiao-Ying Yao

Abstract

The vaccine directed against human chorionic gonadotropin (hCG) has previously undergone clinical test demonstrating the feasibility of the approach in preventing pregnancy in women. Some individuals, however, did not response adequately despite employing highly immunogenic bacterial toxoids as carriers. In this study, we investigated the potential of three copies of C3d as a new molecular adjuvant to enhance the immunogenicity of hCG beta protein antigen. The antibody response to the hCG beta-C3d3 fusion protein immunization was compared with those resulting from immunization with the hCG beta alone and the hCG beta plus CFA/IFA either in BALB/c mice or in C(57)BL/6J mice. Our results showed that the fusion of C3d3 to hCG beta protein antigen resulted in a significant elevation of the serum anti-hCG beta antibody level in the two mouse strains and the antibodies were capable of effectively neutralizing the bioactivity of hCG. The immunization with C3d3 as a molecular adjuvant favored Th2 bias of immune response. The immunity-enhancing effect of the C3d3 was 10-fold (initial) and 20-32-fold (booster) greater than CFA/IFA. These findings indicated that fusion of C3d3 to hCG beta, as a means of harnessing the adjuvant potential o...Continue Reading

References

Aug 30, 1994·Proceedings of the National Academy of Sciences of the United States of America·G P TalwarK Buckshee
Jan 1, 1997·European Journal of Immunology·S A BoackleD R Karp
Jun 3, 2000·Annual Review of Immunology·D T Fearon, M C Carroll
Mar 21, 2001·Vaccine·J AucouturierV Ganne

❮ Previous
Next ❯

Citations

Apr 23, 2021·Proceedings of the National Academy of Sciences of the United States of America·Jason Y H Chang, Darrell J Irvine
Apr 21, 2021·Proceedings of the National Academy of Sciences of the United States of America·Kelly M HainlineJoel H Collier

❮ Previous
Next ❯

Related Concepts

Related Feeds

Avian Influenza: Innate Immune Adjuvant (ASM)

Adjuvants systems that are added to vaccines against avian influenza have be explored to enhance the innate immune system response against the virus. Here is the latest research on avian influenza and the innate immune adjuvant.

B cell Activation

B cell activation is initiated by the ligation of the B cell receptor with antigen and ultimately results in the production of protective antibodies against potentially pathogenic invaders. Here is the latest research.

Avian Influenza: Innate Immune Adjuvant

Adjuvants systems that are added to vaccines against avian influenza have be explored to enhance the innate immune system response against the virus. Here is the latest research on avian influenza and the innate immune adjuvant.